^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
FL-101
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Leap Therap
Drug class:
IL-1β inhibitor
Related drugs:
Phase 1
Flame Biosciences
Withdrawn
Last update posted :
08/19/2022
Initiation :
08/22/2022
Primary completion :
11/28/2022
Completion :
12/28/2022
CRP
|
FL-101
Phase 2
Flame Biosciences
Withdrawn
Last update posted :
01/11/2022
Initiation :
08/25/2021
Primary completion :
12/22/2021
Completion :
12/22/2021
CRP
|
Opdivo (nivolumab) • FL-101
Share
